TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Reports Second Quarter Fiscal Year 2013 Financial

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2013-02-19
Original SEC Filing: Click here


Webplus: TPI/20130219/8-K/2_EX-99.1/000.htm SEC Original: f8k021413ex99i_tianyin.htm
TPI Reports Second Quarter Fiscal Year 2013 Financial Results Tianyin Pharmaceutical Inc. CHENGDU, China, February 14, 2013 — Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue was $17.6 million compared with $18.2 million in 2Q12 a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in 2Q12, an




Webplus: TPI/20130219/8-K/3_EX-99.2/000.htm SEC Original: f8k021413ex99ii_tianyin.htm
Tianyin Pharmaceutical Co., Inc. (“TPI”) Second Quarter of Fiscal Year 2013 Earnings Call February 14, 2013 Operator TPI James Tong Second Quarter Fiscal Year 2013 Ended December 31, 2012 Financial Highlights: ● Revenue totaled $17.6 million compared with $18.2 million in 2Q12, a decrease of 3.3% year over year, ● Operating income was $2.6 million, compared with $2.1 million in




Webplus: TPI/20130219/8-K/1/000.htm SEC Original: f8k021413_tianyin.htm
CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 14, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o



Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2013-02-19CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041

Home Page Forums

By | 2016-03-27T18:44:25+00:00 February 19th, 2013|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar